Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD
Key facts
- Who runs it
- The University of Texas at Dallas
- Where
- Addison, Dallas, and Tallahassee, United StatesSee the 3 sites
- Trial code
- Status
- Recruiting
- People taking part
- 330 people, planned
- Started
- 1 May 2019
- Expected to end
- 1 Jan 2028
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Active rTMS
- Sham rTMS
- Cognitive Processing Therapy
- Record updated
- 20 August 2026
Who can take part
- Age
- 18 years to 60 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 23 criteriaShow less
Who can take part
- Veterans of Post-9/11 military conflicts
- with diagnosis of PTSD based on CAPS-5 related to Post-9/11 military combat
Who cannot take part
- PTSD-inducing trauma exposure occurring within the last 3 months prior to pre-enrollment evaluation
- previous rTMS
- history of epilepsy or seizure disorder, a history of major head trauma,
- any neurologic condition likely to increase risk of seizures,
- moderate to severe substance use disorder in last 3 months or any substance use that puts the participant at increased risk or significant impairment
- stroke, and blood vessel abnormalities in the brain,
- dementia,
- Parkinson's disease, Huntington's chorea, or multiple sclerosis
- a lifetime history of psychotic disorder or bipolar disorder
- inability to stop taking any medication that significantly lowers the seizure threshold
- We will screen for a history of traumatic brain injury and exclude potential participants from the study if they have a history of severe TBI or are at high risk for seizures
- history of seizures
- cardiac pacemaker, implanted medication pumps of any sort that would increase the risk of rTMS
- any current medical condition that could preclude being able to safely participate in TMS treatment,
- use of prescription medication or illegal substances that lower the seizure threshold
- current enrollment in an acute experimental treatment for PTSD or trauma-focused psychotherapy treatment
- brain tumors,
- a high suicide risk
- pregnant or nursing
- metal fragments in the head, or any metal objects in or near the head that cannot be safely removed
- non-English speakers because not all of the screening forms, questionnaires, and tests are available in any language except for English
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 60 years old?
This trial is currently available in United States.
- Metrocare Services of DallasAddison, United StatesContact: Steven A Cohen Military Family Clinic at MetrocareTaking people
- The University of Texas at DallasDallas, United StatesContact: Celia HigginbothamTaking people
- Florida State University College of MedicineTallahassee, United StatesContact: FSU NeuromodulationTaking people
About the trial
What the trial wants to find out
The purpose of this study is to examine the benefits of combining repetitive Transcranial Magnetic Stimulation (rTMS) coupled with Cognitive Processing Therapy (CPT) in treating combat-related Posttraumatic Stress Disorder (PTSD) symptoms. The study will also examine change in depression, psychosocial functioning, and neurophysiological (i.e., electroencephalography and magnetic resonance images) measures.
The 3 groups in the trial
- Sham rTMS + CPTSham treatment, for comparison
30 minutes of sham repetitive transcranial magnetic stimulation (rTMS) to the right dorsolateral prefrontal cortex (rDLPFC) prior to each Cognitive Processing Therapy (CPT) session
Treatment: Active rTMS and Cognitive Processing Therapy
- Active rTMS + CPTExisting treatment, for comparison
30 minutes of 1 Hz rTMS to rDLPFC prior to each CPT session
Treatment: Sham rTMS and Cognitive Processing Therapy
- Active rTMS AloneExisting treatment, for comparison
30 minutes of 1 Hz rTMS to rDLPFC at 1 session per week over 12 weeks
Treatment: Active rTMS
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT03932773, who can take part
- Record updated
- 20 August 2026